Farmax India Ltd vs HINDUSTAN UNILEVER LTD.
A side-by-side comparison of Farmax India Ltd (FARMAXIND) and HINDUSTAN UNILEVER LTD. (HINDUNILVR) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, HINDUSTAN UNILEVER LTD. leads FARMAXIND vs HINDUNILVR on 10 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation22
- Profitability04
- Growth01
- Size & financial health13
Valuation
EvenHow expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
HINDUNILVR takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
HINDUNILVR takes 1/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
HINDUNILVR takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has reduced debt.", "Stock is trading at 0.12 times its book value"]
- − ["Company has low interest coverage ratio.", "The company has delivered a poor sales growth of -27.3% over past five years.", "Company might be capitalizing the interest cost", "Debtor days have increased from 89.4 to 144 days."]
- + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 92.4%"]
- − ["Stock is trading at 9.69 times its book value", "The company has delivered a poor sales growth of 6.51% over past five years.", "Earnings include an other income of Rs.4,933 Cr."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.